Clinical trial
A Non-interventional Trial With Avastin as Front-line Treatment for Ovarian Cancer
NCT01788995 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Non-interventional Trial With Avastin as Front-line Treatment for Ovarian Cancer
- Lead sponsor
- Hoffmann-La Roche
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 15, 2012
- Completion date
- October 11, 2018
- Enrollment
- 63 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ovarian cancer, peritoneal neoplasms